Followers | 2 |
Posts | 254 |
Boards Moderated | 0 |
Alias Born | 06/02/2020 |
Thursday, January 21, 2021 6:29:40 PM
Animal Devices– The key difference between an animal device and an animal drug is how the product works. If it relies on a chemical action occurring in or on the animal’s body to work, the product is a drug, not a device. If it needs to be metabolized by the animal’s body to work, the product is a drug, not a device.
Antibiotics, anesthetics, and insulin are examples of drugs. Needles, syringes, surgical instruments, X-ray equipment, certain diagnostic test kits, and dental appliances are examples of devices.
Unlike animal drugs, animal devices do not have to be approved by FDA before they can be marketed. Manufacturers and distributers of animal devices are responsible for making sure they are safe, effective, and properly labeled. FDA has the authority to take regulatory action if an animal device is adulterated or misbranded.
For the complete definition of the term “device,” please see the Federal Food, Drug, and Cosmetic Act at Section 201(h) [21 U.S.C. 321].
For more information about animal devices, please visit: How FDA Regulates Animal Devices
https://www.fda.gov/animal-veterinary/animal-health-literacy/what-fda-does-and-does-not-regulate#Devices
Recent ZOM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:32:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 07:54:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:17:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 04:03:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/20/2024 11:12:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:16:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:11:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:07:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:06:12 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:18:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:22:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:49 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM